Search Results - "STRICKLEY, R. G"
-
1
Solubilizing excipients in oral and injectable formulations
Published in Pharmaceutical research (01-02-2004)“…A review of commercially available oral and injectable solution formulations reveals that the solubilizing excipients include water-soluble organic solvents…”
Get full text
Journal Article -
2
Parenteral formulations of small molecules therapeutics marketed in the United States (1999). Part III
Published in PDA journal of pharmaceutical science and technology (01-03-2000)Get more information
Journal Article -
3
Solubilization and stabilization of an anti-HIV thiocarbamate, NSC 629243, for parenteral delivery, using extemporaneous emulsions
Published in Pharmaceutical research (01-07-1993)“…The O-alkyl-N-aryl thiocarbamate, I, (2-chloro-5-[[(1-methyl-ethoxy)thioxomethyl]amino]benzoic acid, 1-methylethylester, NSC 629243, also known as Uniroyal…”
Get full text
Journal Article -
4
-
5
Solid-state stability of human insulin. II. Effect of water on reactive intermediate partitioning in lyophiles from pH 2-5 solutions: stabilization against covalent dimer formation
Published in Journal of pharmaceutical sciences (01-06-1997)“…Previous studies have established that at low pH human insulin decomposition proceeds through a two-step mechanism involving rate-limiting intramolecular…”
Get more information
Journal Article -
6
Solid-state stability of human insulin I. Mechanism and the effect of water on the kinetics of degradation in lyophiles from pH 2-5 solutions
Published in Pharmaceutical research (01-08-1996)“…Previous studies have established that in aqueous solution at low pH human insulin decomposition proceeds through a cyclic anhydride intermediate leading to…”
Get full text
Journal Article -
7
Drug-excipient incompatibility studies of the dipeptide angiotensin-converting enzyme inhibitor, moexipril hydrochloride : dry powder vs wet granulation
Published in Pharmaceutical research (01-04-1990)“…The drug-excipient incompatibility screen for moexipril hydrochloride (1) using various isothermal stress methods is reported herein. It was found that most of…”
Get full text
Journal Article -
8
Diketopiperazine formation, hydrolysis, and epimerization of the new dipeptide angiotensin-converting enzyme inhibitor RS-10085
Published in Pharmaceutical research (01-10-1987)“…The degradation kinetics, products, and mechanisms of RS-10085(1), 2-[2-(1-ethoxycarbonyl)-3-phenylpropyl]amino-1-oxopropyl]-6,7-…”
Get full text
Journal Article -
9
An unexpected pH effect on the stability of moexipril lyophilized powder
Published in Pharmaceutical research (01-11-1989)“…Because of the limited stability of moexipril (RS-10085; 1) in aqueous solution, lyophilized parenteral formulations were evaluated as a function of pH in this…”
Get full text
Journal Article -
10
Preformulation stability studies of the new dipeptide angiotensin-converting enzyme inhibitor RS-10029
Published in Pharmaceutical research (01-12-1988)“…The degradation kinetics, products, and mechanisms of RS-10029 (2), 2-[2-[(1-carboxylic acid)-3-phenylpropyl]amino-1-oxopropyl] 6,7-dimethoxy-…”
Get full text
Journal Article -
11
Parenteral formulations of small molecules therapeutics marketed in the United States (1999)--Part I
Published in PDA journal of pharmaceutical science and technology (01-11-1999)Get more information
Journal Article -
12
Pediatric drugs--a review of commercially available oral formulations
Published in Journal of pharmaceutical sciences (01-05-2008)“…Pediatric oral formulations can be quite scientifically challenging to develop and the prerequisites for both a measurable dosage form to administer based upon…”
Get more information
Journal Article -
13
High-performance liquid chromatographic (HPLC) and HPLC-mass spectrometric (MS) analysis of the degradation of the luteinizing hormone-releasing hormone (LH-RH) antagonist RS-26306 in aqueous solution
Published in Pharmaceutical research (01-05-1990)“…The kinetics of the degradation of an LH-RH antagonist, RS-26306,1, in aqueous solution from pH 1 to pH 11 were studied by reverse-phase HPLC. The pH-rate…”
Get full text
Journal Article -
14
Parenteral formulation development for the positive inotropic agent RS-82856: solubility and stability enhancement through complexation and lyophilization
Published in Journal of parenteral science and technology : a publication of the Parenteral Drug Association (01-07-1987)Get more information
Journal Article -
15